Sigma-1受体激活协调代谢应激反应保护缺血性视网膜病变血管
本研究在氧诱导视网膜病变(OIR)小鼠模型中探究Sigma-1受体(Sig1R)激活对视网膜血管的保护作用。结果显示,Sig1R激活可恢复代谢应激相关蛋白水平、抑制氧化应激和炎症、改善血管屏障完整性并减少病理性新生血管,且该保护作用依赖于Sig1R。
要点
- Sig1R激活恢复Cul3和pAMPK水平,抑制pAkt/eNOS信号,减轻代谢与内皮应激。
- Sig1R激活降低VEGF、IL-6、TNF-α等促血管生成和炎症介质,减少氧化应激。
- Sig1R激活改善血管屏障、减少动脉迂曲和病理性新生血管,促进无血管区再血管化。
核心结论
- Sig1R激活可保护OIR视网膜血管完整性并抑制病理性血管生成。
- Sig1R激活的血管保护作用依赖于Sig1R,在Sig1R-/-小鼠中无血管获益。
- 结合已知神经保护效应,Sig1R是ROP有前景的双重神经血管治疗靶点。
研究设计与样本
- 研究采用氧诱导视网膜病变(OIR)小鼠模型。
- 在野生型和Sig1R-/-小鼠中给予或不给予全身性(+)-喷他佐辛([+]-PTZ)以激活Sig1R。
- 通过荧光血管造影和视网膜铺片分析评估血管病理、屏障完整性和无血管区。
- 通过免疫染色/印迹和ELISA评估代谢、氧化和炎症通路的分子变化。
主要发现
- OIR视网膜中Sig1R表达降低,伴Cul3和pAMPK降低、pAkt和eNOS升高。
- (+)-PTZ激活Sig1R后恢复Sig1R、Cul3和pAMPK水平,抑制pAkt/eNOS信号,减少氧化应激和Müller胶质细胞活化。
- (+)-PTZ显著降低OIR诱导的p-STAT3及VEGF、IL-6、TNF-α、M-CSF、VCAM-1和TNFR等促血管生成/炎症介质上调。
- 功能上,Sig1R激活改善视网膜血管屏障完整性,减少动脉迂曲和病理性新生血管,促进无血管视网膜再血管化。
- 在Sig1R-/-小鼠中(+)-PTZ未产生任何血管获益,证实血管获益依赖Sig1R。
临床怎么用
- Sig1R激活可能作为ROP中同时保护神经和血管的潜在治疗策略。
- 靶向Sig1R或可弥补现有抗新生血管治疗未能完全恢复血管完整性的不足。
局限性
- 研究为动物实验(OIR小鼠模型),结果尚未在人体中验证。
- 原文未报告样本量、具体效应值或统计阈值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Retinopathy of prematurity (ROP)-associated vision loss is driven by pathological retinal angiogenesis. Current therapies suppress neovascularization but do not fully restore vascular integrity or prevent long-term visual deficit. Activation of the sigma-1 receptor (Sig1R) has been reported to confer neuroprotection, yet its role in retinal vascular protection remains largely unexplored. Here, we investigated whether Sig1R activation confers vascular protection in experimental ROP. METHODS: The oxygen-induced retinopathy (OIR) mouse model was induced in wild-type and Sig1R-/- mice with or without systemic (+)-pentazocine ([+]-PTZ) administration to activate Sig1R. Retinal vascular pathology, barrier integrity, and avascular areas were evaluated by fluorescein angiography and retinal flatmount analysis. Molecular changes in metabolic, oxidative, and inflammatory pathways were assessed by immunostaining/blotting and ELISA assay. RESULTS: Sig1R expression was reduced in OIR retinas, accompanied by decreased cullin-3 ubiquitin ligase (Cul3) and phosphorylated AMP-activated protein kinase (pAMPK) and increased pAkt and endothelial nitric oxide synthase (eNOS), indicative of metabolic and endothelial stress. Activation of Sig1R with (+)-PTZ restored Sig1R, Cul3, and pAMPK levels, suppressed pAkt/eNOS signaling, reduced oxidative stress, and attenuated Müller glial activation. OIR-induced upregulation of phosphorylated signal transducer and activator of transcription 3 (p-STAT3) and pro-angiogenic/inflammatory mediators, including vascular endothelial growth factor (VEGF), IL-6, TNF-α, macrophage colony-stimulating factor (M-CSF), vascular cell adhesion molecule 1 (VCAM-1), and tumor necrosis factor receptor (TNFR), were markedly reduced by (+)-PTZ. Functionally, Sig1R activation improved retinal vascular barrier integrity, reduced arterial tortuosity and pathological neovascularization, and promoted revascularization of avascular retina. Importantly, (+)-PTZ treatment failed to confer any vascular benefit in Sig1R-/- mice, confirming that these vascular benefits are Sig1R dependent. CONCLUSIONS: Sig1R activation preserves vascular integrity and suppresses pathological angiogenesis in OIR. Together with known neuroprotective effects, Sig1R represents a promising dual neurovascular therapeutic target for ROP.
引用
- Wang J, Lu X, Lu Z, et al. Sigma 1 Receptor Activation Coordinates Metabolic Stress Responses to Protect Retinal Vasculature in Ischemic Retinopathy. Invest Ophthalmol Vis Sci. 2026. PMID: 42376995. doi:10.1167/iovs.67.6.58
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。